carcinoma di Merkel - Dermatologia

ott
2022

The impact of merkel cell polyomavirus

Ricerca

There are numerous findings over the past decade have indicated that Merkel cell carcinoma (MCC) may have two pathways of pathogenesis...

lug
2022

Clinical impact of immunotherapy in Merkel cell carcinoma patients

Ricerca

Immunotherapy is emerging as an alternative treatment for Merkel cell carcinoma, but its long-term effects on response, survival, and safety are not well established....

giu
2022

Sentinel lymph node biopsy in Merkel cell carcinoma

Ricerca

Sentinel lymph node biopsy in Merkel cell carcinoma: Rates and predictors of compliance with the National Comprehensive Cancer Network guidelines...

mar
2022

Merkel cell carcinoma

Ricerca

Merkel cell carcinoma is a rare neuroendocrine carcinoma that typically appears in sun-exposed areas of the elderly....

lug
2021

Immune checkpoint inhibitors to treat cutaneous malignancies

Ricerca

As the incidence of cutaneous malignancies continues to rise and their treatment with immunotherapy expands, dermatologists and their patients are more likely to encounter immune checkpoint inhibitors....

nov
2020

Analysis of cutaneous Merkel cell carcinoma outcomes after different surgical interventions

Ricerca

Current guidelines recommend local excision margin (EM) with 1 to 2 cm on primary Merkel cell carcinoma (MCC) sites....

giu
2017

Triple Immunotherapy for Metastatic Merkel Cell Carcinoma Shows Promise

Rassegna stampa

Three out of four patients treated with an experimental combination of 3 different therapies for metastatic Merkel cell carcinoma are in complete remission following the treatment, according to study that will be presented on June 5 at...

apr
2017

Avelumab Provides Durable Responses in Patients With Distant Metastatic Merkel Cell Carcinoma

Rassegna stampa

Avelumab provided durable responses in patients with distant metastatic Merkel cell carcinoma who had progressed after chemotherapy, according to a study presented here at the 2017 Annual Meeting of the American Association for Cancer ...

apr
2017

FDA Approves Avelumab for Metastatic Merkel Cell Carcinoma

Rassegna stampa

The US Food and Drug Administration (FDA) has granted accelerated approval to avelumab (Bavencio) for the treatment of patients aged 12 years and older with metastatic Merkel cell carcinoma (MCC)....

lug
2011